SLC1A2 and congenital rubella syndrome: To evaluate the role of GLT-1 in our experimental model, we assessed the effects of systemic ceftriaxone, a known GLT-1 enhancer (Rasmussen et al., 2011), on the CRS-induced behavioral cross-sensitization to cocaine following the protocol presented in Figure 4A.